Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

coherus biosciences

POPULAR ARTICLES

An Investor’s Overview to Biosimilars

An Investor’s Overview to Biosimilars

Coherus BioSciences Announces Global Settlement with AbbVie

Pharmaceutical Investing

Coherus BioSciences Announces Positive Topline 24-Week Treatment Phase Three Results for CHS-1420 (HUMIRA® Biosimilar Candidate) in Patients with Psoriasis

LATEST ARTICLES

Coherus BioSciences Announces FDA Acceptance of 351(k) Biologics License Application for CHS-1701

Coherus Announces Positive Phase 2b Efficacy Data on Novel Oral Therapy in Relapsing Remitting Multiple Sclerosis

Coherus BioSciences Provides Update on ‘135 IPR

Coherus BioSciences to Present at Bank of America Merrill Lynch Health Care Conference on May 11

Latest News

McDermitt Project Fast-Tracked Under U.S. FAST-41 Initiative

Providence Update on Tuolumne Property Lease

Athena Gold Upsizes Flow-Through Private Placement, Announces Concurrent Hard Dollar Unit Offering

Westport Announces Annual General and Special Meeting and Timing of Q1 2025 Financial Results

Finlay Minerals Enters into Earn-In Agreements with Freeport for its PIL & ATTY Properties